Does tocilizumab contribute to elevation of rheumatoid factor and induction of paradoxical syaloadenitis in rheumatoid arthritis patients?

Author： Martinović Kaliterna Dušanka   Aljinović Jure   Perković Dijana   Marasović Krstulović Daniela   Marinović Ivanka   Vlak Tonko  

Publisher： Springer Publishing Company

ISSN： 0043-5325

Source： Wiener klinische Wochenschrift, Vol.126, Iss.3-4, 2014-02, pp. : 126-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 10, 2015-10 ,pp. : 1354-1362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 2151-464X, Iss. 10, 2015-10 ,pp. : 1354-1362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 1, 2015-01 ,pp. : 108-110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of Anti–Citrullinated Protein Antibodies and IgM Rheumatoid Factor in First‐Degree Relatives of Dutch Rheumatoid Arthritis Patients

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 12, 2015-12 ,pp. : 3324-3326

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hearing status in patients with rheumatoid arthritis

By  

Journal of Laryngology and Otology, Vol. 131, Iss. 10, 2017-10 ,pp. : 895-899

Cambridge University Press

Access to resources Recommend Favorite